Is GenLight MedTech a funded company?

GenLight MedTech is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does GenLight MedTech rank among its competitors?

GenLight MedTech ranks 14th amongst 20 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Cadence Neuroscience, which secured $26M in Feb, 2023.

Who are the top competitors of GenLight MedTech?

GenLight MedTech's top competitors include NeuroPace, LivaNova and Cyberonics. Among them, Cadence Neuroscience secured the most recent funding round in February, 2023.

GenLight MedTech - 2026 Company Profile & Competitors

GenLight MedTech is an unfunded company. It operates as a Developer of innovative treatment solutions for epilepsy and other neurological diseases. GenLight MedTech has not raised any funding yet. The company has 20 active competitors, including 4 funded and 5 that have exited. Its top competitors include companies like NeuroPace, LivaNova and Cyberonics.

Company Details

Developer of innovative treatment solutions for epilepsy and other neurological diseases. They focus on brain-machine control, high-end medical lasers, and brain-machine chips to provide medical device solutions for various neurological disorders.

Key Metrics

Stage

Unfunded

Ranked

14^th among 20 active competitors

Similar Companies

NeuroPace & 22 more

View GenLight MedTech's full profile

GenLight MedTech has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of GenLight MedTech include NeuroPace, LivaNova and Cyberonics. Here is the list of Top 10 competitors of GenLight MedTech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroPace 1997, Mountain View (United States), Public	Developer of implantable neurostimulation system for epilepsy treatment	$264M	New Enterprise Associates, Technology Partners ... & 15 others	65/100
2nd	LivaNova 2015, London (United Kingdom), Public	Provider of cardiac and neurological therapeutic devices	-	Ministry of Economic Development, Comvest Partners ... & 3 others	61/100
3rd	Cyberonics 1987, Houston (United States), Public	Vagus nerve stimulation device for epilepsy and treatment resistant depression	-	-	45/100
4th	Engage Therapeutics 2017, Summit (United States), Acquired	Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures	$30.6M	Adage Capital Management, Lumira Ventures ... & 5 others	42/100
5th	Cadence Neuroscience 2016, Redmond (United States), Series B	Developer of medical devices for treating neurological disorders	$41M	JAZZ Venture Partners, Angelini Lumira Biosciences Fund ... & 10 others	40/100
6th	Precisis 2002, Heidelberg (Germany), Funding Raised	Portfolio of devices and tools for neurological surgery	-	Lifeblood Capital, EIC Fund & 1 others	38/100
7th	NeuroVice 2016, Cary (United States), Funding Raised	Developing innovative oral health solutions for seizure-related injuries and improving patient experience	-	-	38/100
8th	Neurolink 2007, San Antonio (United States), Deadpooled	Drug-device combination for epilepsy	$3.88M	InCube Ventures, North Texas RCIC & 1 others	30/100
9th	NightWatch 2013, Leiden (Netherlands), Series A	Provider of wearable device for epilepsy seizure detection during sleep	-	Holland Capital, Health Innovations & 3 others	30/100
10th	CerboMed 2005, Erlangen (Germany), Series A	A medical device company which engages in developing neuro therapy solutions.	$2.6M	KfW, Sobera Capital & 3 others	28/100
14th	GenLight MedTech Unfunded	Developer of innovative treatment solutions for epilepsy and other neurological diseases	-	-	24/100